Clinical trials have established that, at its maximum dose, metformin can help decrease A1C levels by 1.5 percent, while an average dose of Ozempic can decrease A1C by 1.4 percent
To read the story, click here
As oral GLP-1 therapies move closer to commercialization, the importance of robust chemical manufacturing, high-quality intermediates, and process reliability will continue to grow
The efficacy and safety of agomelatine, sertraline, and escitalopram for senile post-stroke depression: a randomized double-blind placebo-controlled trial
Here, we reported that a protein-protein interaction between dopamine D2 receptor (D2R) and dopamine transporter (DAT) provides a new way to modulate the activities of DAT and dopamine reuptake